Table 2.
—Hospital Treatment Practices and Outcomes of Patients Hospitalized With AMI According to a History of COPD and Period of Hospitalization
| 1997/1999 |
2005/2007 |
|||
| Therapies/Outcomes | COPD Present | COPD Absent | COPD Present | COPD Absent |
| ACE inhibitors | 50.5 | 50.1 | 71.4 | 64.9a |
| Anticoagulants | 48.3 | 57.5a | 81.7 | 80.2 |
| Aspirin | 89.0 | 92.2 | 92 | 95.6a |
| β-Blockers | 64.6 | 84.6b | 93.4 | 95 |
| Calcim channel blockers | 42.3 | 25.2b | 24.3 | 20.8 |
| Lipid lowering | 25.0 | 32.4c | 76.0 | 79.0 |
| Cardiac catheterization | 28.6 | 44.0b | 53.2 | 69.3b |
| PCI | 11.0 | 20.3b | 36.5 | 51.8b |
| CABG | 3.8 | 5.8 | 5.7 | 5.6 |
| Atrial fibrillation | 17.6 | 13.6 | 28.2 | 20.7c |
| Heart failure | 46.4 | 32.2b | 55.2 | 36.9b |
| In-hospital mortality | 11 | 12 | 14.4 | 8.7c |
| 30-d mortality | 15 | 14.7 | 18.7 | 12.3c |
ACE = angiotensin-converting enzyme; CABG = coronary artery bypass surgery; PCI = percutaneous coronary intervention. See Table 1 legend for expansion of other abbreviation.
a
P < .05 patients with COPD compared with patients without COPD in each cohort.
b
P < .001 patients with COPD compared with patients without COPD in each cohort.
c
P < .01 patients with COPD compared with patients without COPD in each cohort.